Medivolve Inc.
MEDVF
$0.002
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -691.30K | -6.16M | -- | -1.27M | -2.15M |
| Total Depreciation and Amortization | 38.00K | -101.80K | -- | -37.30K | 117.40K |
| Total Amortization of Deferred Charges | -- | 139.70K | -- | -- | -- |
| Total Other Non-Cash Items | -181.50K | 5.48M | -- | 530.00K | 765.80K |
| Change in Net Operating Assets | 442.10K | 97.50K | -- | 1.26M | -422.50K |
| Cash from Operations | -392.70K | -540.20K | -- | 625.30K | -1.69M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -3.90K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -3.90K | -- | -183.00K | -- |
| Total Debt Issued | -- | 0.00 | -- | 0.00 | 1.20M |
| Total Debt Repaid | -19.80K | -41.30K | -- | -12.70K | -1.46M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.70K | -30.40K | -- | -10.90K | -191.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | -- | -- | -- |
| Net Change in Cash | -407.40K | -574.50K | -- | 431.50K | -1.88M |